Long-term treatment with high-dose of sildenafil in a thalassemic patient with pulmonary hypertension

Monaldi Archives for Chest Disease - Cardiac Series

Volumn 78, Issue 2, 2012, Pages 105-106

  Correale, Michele ^a   De Rosa, Fiorella ^a   Ieva, Riccardo ^a   Di Biase, Matteo ^a   Brunetti, NataleDaniele ^a  

^a UNIVERSITY OF FOGGIA   (Italy)

Author keywords

Pulmonary arterial hypertension; Sildenafil; Thalassemia major

Indexed keywords

SILDENAFIL; ANTICOAGULANT AGENT;

ADULT; ARTICLE; CASE REPORT; DIABETES MELLITUS; DISEASE SEVERITY; DRUG MEGADOSE; DYSPNEA; HEPATITIS C; HUMAN; HYPOGONADOTROPIC HYPOGONADISM; LONG TERM CARE; LUNG ARTERY PRESSURE; LUNG EMBOLISM; MALE; OSTEOPOROSIS; PULMONARY HYPERTENSION; THALASSEMIA; ANTICOAGULANT THERAPY; CHRONIC HEPATITIS C; CLINICAL FEATURE; DISEASE ASSOCIATION; DOSE RESPONSE; DRUG EFFECT; SYSTOLIC BLOOD PRESSURE; THALASSEMIA MAJOR; TWO DIMENSIONAL ECHOCARDIOGRAPHY;

EID: 84869229235     PISSN: 11220643     EISSN: None     Source Type: Journal    
DOI: 10.4081/monaldi.2012.131     Document Type: Article

References (4)

1. Cogliandro T, Derchi G, Mancuso L et al. Guideline recommendations for heart complications in thalassemia major. J Cardiovasc Med (Hagerstown). 2008; 9(5): 515-525. (Pubitemid 351521635)
2. The Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS), endorsed by the International Society of Heart and Lung Transplantation (ISHLT). Guidelines for the diagnosis and treatment of pulmonary hypertension. European Heart Journal 2009; 30: 2493-2537.
3. Littera R, La Nasa G, Derchi G et al. Long-term treatment with oral sildenafil in a thalassemic patient with pulmonary hypertension. Blood 2002; 100: 1516-1517. (Pubitemid 34864323)
4. Derchi G, Forni GL, Formisano F et al. Efficacy and safety of sildenafil in the treatment of severe pulmonary hypertension in patients with hemoglobinopathies. Haematologica 2005; 90: 452-458. (Pubitemid 40592887)